Bluechiip Limited Stock Market Press Releases and Company Profile
Sales of Starter Kits to Two Key Institutions
Sales of Starter Kits to Two Key Institutions

Melbourne, Nov 9, 2016 AEST (ABN Newswire) - Bluechiip Limited (googlechartASX:BCT), a leader in the development of sample tracking technology for harsh environments, today announced that it has sold three Starter Kits, which include Bluechiip readers and 4,000 associated consumables.

One, via the Chinese distributor, went to the Chinese Centre for Disease, Control and Prevention (CCDC), an agency of the Chinese Ministry of Health based in Beijing.

This was the second sale to the CCDC, which previously bought a kit in July 2016. Two Starter Kits went to the Prague-based subsidiary of SIAD, a European biobank solution provider for the life sciences sector, manufacturer of technical gases and medical gases, healthcare provider and medical devices distributor. SIAD-CZ has signed a distribution contract with Bluechiip, and aims to distribute the company's technology in Eastern Europe, with exclusivity in Czech Republic, Slovakia, Poland and Hungary.

Bluechiip and SIAD-CZ are looking to collaborate with respect to sales and marketing of Bluechiip's products.

Andrew McLellan, Bluechiip's CEO, said the three sales continue Bluechiip's momentum.

"We are thrilled to have made a repeat sale to the Chinese Centre for Disease, Control and Prevention. This will provide a further reference point for both OEM partners and end users. We are also excited to have sold kits to a distributor in Europe, which will eventually lead to more sales; Starter Kits are the first step toward a successful rollout of our full suite of products," he said.

"Importantly, Starter Kits allow purchasers to become familiar with Bluechiip's technology and to train staff in their use. These sales continue to confirm the value of Bluechiip's technology to OEM partners and end customers that need to effectively control sample integrity through the chain of custody."

About Bluechiip Limited

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

https://twitter.com/bluechiip https://www.youtube.com/channel/UCaVcyO4O2oJ_9fLdMs6JIyQ https://www.linkedin.com/company/bluechiip-limited abnnewswire.com 


Contact

Corporate enquiries
Andrew McLellan
Managing Director - CEO
Ph: +61-457-823-470
andrew.mclellan@bluechiip.com

Media
Richard Allen
Ph: +61-3-9915-6341
Oxygen Financial PR
richard@oxygenpr.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 10) (Last 30 Days: 25) (Since Published: 3412)